Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

Applicable To

Long term (current) use of estrogen receptor downregulators
Long term (current) use of fulvestrant (Faslodex)
Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
Long term (current) use of goserelin acetate (Zoladex)
Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
Long term (current) use of megestrol acetate (Megace)

GEM Conversion to ICD-9 CM


MDC / MS-DRG Reference


Back Reference of Diagnostic Codes


Sibling Codes


Parent Sibling Codes


Codes with Same Suffix


View in Tabular

Code Title
Z00-Z99 Factors influencing health status and contact with health services (Z00-Z99)
Z77-Z99 Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
Z79 Long term (current) drug therapy
Z79.8 Other long term (current) drug therapy
Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels
Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Applicable to
Long term (current) use of estrogen receptor downregulators
Long term (current) use of fulvestrant (Faslodex)
Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
Long term (current) use of goserelin acetate (Zoladex)
Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
Long term (current) use of megestrol acetate (Megace)